Napajen Pharma

Developer of oligonucleotide therapeutics for immune diseases

placeBurlingame, California, United States calendar_todayFounded 2004 groups3 employees language napajen.com

Innovation

13 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 345 times.

YearFilings
20123
20133
20143
20151
20173
20185
20194
20204
20214
20224
20232
20242

Investor mix

5 investors on record; lead investors include INCJ.

Investor typeCountShare
Venture capital240%
Private equity120%
Other / undisclosed240%
Coming soon